These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3829580)

  • 21. Hyperlactataemia in phenformin-treated diabetics.
    Varma SK; Heaney SJ; Whyte WG; Walker RS
    Br Med J; 1972 Jan; 1(5794):205-6. PubMed ID: 5058730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lactic acidosis in metformin therapy.
    Lalau JD; Race JM
    Drugs; 1999; 58 Suppl 1():55-60; discussion 75-82. PubMed ID: 10576527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Physiopathological approach to pathological hyperlactatemia in the diabetic patient. Value of blood metformin].
    Lambert H; Isnard F; Delorme N; Claude D; Bollaert PE; Straczek J; Larcan A
    Ann Fr Anesth Reanim; 1987; 6(2):88-94. PubMed ID: 3109285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood lactate and pyruvate levels in diabetic patient treated with sulphonylureas with and without biguanides.
    Sitprija S; Vajanamarhutue C; Bunnag S
    J Med Assoc Thai; 1982 Feb; 65(2):63-71. PubMed ID: 7077214
    [No Abstract]   [Full Text] [Related]  

  • 25. [Semi-automatic determination of blood lactate during hypoglycemic treatment with biguanides].
    Gelo Signorino R; Castellazzi R; Gamba S; Grassi G; Zanno C; Bruni B
    Ann Osp Maria Vittoria Torino; 1979; 22(1-6):18-37. PubMed ID: 122229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperlactatemia in diabetics with retinopathy during combined sulphonylurea and phenformin therapy.
    Nattrass M; Arthur MJ; Smythe P; McGill JI; Todd PG; Alberti KG
    Diabete Metab; 1978 Mar; 4(1):1-4. PubMed ID: 668976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biguanide-induced lactic acidosis.
    Chandalia HB; Rangnath M
    J Assoc Physicians India; 1990 Sep; 38(9):620-2. PubMed ID: 2266074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 diabetes in the elderly: an assessment of metformin (metformin in the elderly).
    Lalau JD; Vermersch A; Hary L; Andrejak M; Isnard F; Quichaud J
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):329-32. PubMed ID: 2272714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum concentration of lactate in diabetic patients treated with biguanides in relationship to renal function (author's transl)].
    Sailer D; Ganawal S; Berg G
    Med Klin; 1979 Mar; 74(9):318-24. PubMed ID: 423858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the lactate and pyruvate levels of the blood and of the lactate-pyruvate ratio in patients with diabetes treated with phenethylbiguanide.
    Guarnieri GF; Previato G; Barbui T; Di Luzio V; Faccini L
    Arzneimittelforschung; 1969 Dec; 19(12):2007-10. PubMed ID: 5395893
    [No Abstract]   [Full Text] [Related]  

  • 32. Metformin treatment in NIDDM patients with mild renal impairment.
    Connolly V; Kesson CM
    Postgrad Med J; 1996 Jun; 72(848):352-4. PubMed ID: 8758014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactic acidosis in phenformin-treated diabetics. A clinical and laboratory study.
    Bengtsson K; Karlberg B; Lindgren S
    Acta Med Scand; 1972 Mar; 191(3):203-8. PubMed ID: 4624476
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of oxidation polymorphism on phenformin kinetics and dynamics.
    Oates NS; Shah RR; Idle JR; Smith RL
    Clin Pharmacol Ther; 1983 Dec; 34(6):827-34. PubMed ID: 6641100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Solid phase extraction--non-aqueous capillary electrophoresis for determination of metformin, phenformin and glyburide in human plasma.
    Lai EP; Feng SY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Oct; 843(1):94-9. PubMed ID: 16787767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Body mass index, blood lactate and therapeutic effectiveness of metformin in type II diabetes mellitus].
    Gregorio F; Ambrosi F; Angelici F; Cristallini S; Dini FL; Vespasiani G; Santeusanio F; Filipponi P
    Medicina (Firenze); 1989; 9(2):200-4. PubMed ID: 2682123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dried blood spot testing for estimation of renal function and analysis of metformin and sitagliptin concentrations in diabetic patients: a cross-sectional study.
    Scherf-Clavel M; Albert E; Zieher S; Valotis A; Hickethier T; Högger P
    Eur J Clin Pharmacol; 2019 Jun; 75(6):809-816. PubMed ID: 30706085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of phenformin and metformin on fat and carbohydrate metabolism.
    Sulaiman WR; Johnson RH
    Acta Diabetol Lat; 1977; 14(3-4):129-36. PubMed ID: 605743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of biguanides on the intermediate metabolism of glucose in normal and portal-strictured rats.
    Schlienger JL; Frick A; Marbach J; Freund H; Imler M
    Diabete Metab; 1979 Mar; 5(1):5-9. PubMed ID: 446834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of primary hyperlipoproteinemias type IV with different biguanides (author's transl)].
    Weisweiler P; Schwandt P
    Klin Wochenschr; 1976 Mar; 54(6):283-5. PubMed ID: 177803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.